Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy

scientific article published on 21 August 2008

Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.RADONC.2008.07.013
P698PubMed publication ID18722684

P2093author name stringYou Lu
Wenhao Guo
Bingwen Zou
Yongshun Chen
P2860cites work100 years of lung cancerQ34000402
P433issue3
P304page(s)351-358
P577publication date2008-08-21
P1433published inRadiotherapy and OncologyQ14251029
P1476titleDose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy
P478volume88

Reverse relations

cites work (P2860)
Q48256303A SUVmax-based propensity matched analysis of stereotactic body radiotherapy versus surgery in stage I non-small cell lung cancer: unveiling the role of 18F-FDG PET/CT in clinical decision-making
Q38790915A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer
Q61804642Approaches to stereotactic body radiation therapy for large (≥5 centimeter) non-small cell lung cancer
Q40608540Assessing the Need for Adjuvant Chemotherapy After Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Carcinoma
Q31152462Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT
Q28083924Challenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy?
Q38663392Clinical Outcomes of 130 Patients with Primary and Secondary Lung Tumors treated with Cyberknife Robotic Stereotactic Body Radiotherapy
Q34202715Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size
Q48316437Comparative efficacy and toxicity of induction chemotherapy with concurrent stereotactic body radiotherapy and stereotactic body radiotherapy with subsequent chemotherapy in patients with clinical stage T1-3N0M0 non-small cell lung carcinoma
Q57175083Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham's (UK) Experience
Q99582898Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer
Q40542033Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumors
Q91830232Prognostic Role Of Computed Tomography Textural Features In Early-Stage Non-Small Cell Lung Cancer Patients Receiving Stereotactic Body Radiotherapy
Q26823043Radiation dose effect in locally advanced non-small cell lung cancer
Q60912983Stereotactic body radiation therapy for non-small cell lung cancer: A review
Q34304095Stereotactic body radiation therapy for post-pulmonary lobectomy isolated lung metastasis of thoracic tumor: survival and side effects
Q37025540Stereotactic body radiotherapy for T3 and T4N0M0 non-small cell lung cancer.

Search more.